Label Capital made a €5 million minority investment in IVB Wellness Lab, a Spanish holistic supplements brand. WHO: IVB Wellness Lab was co-founded in 2023 by Dr Isabel Viña Bas, an endocrinologist and IVB’s Chief Scientific Officer, and her brothers Carlos and Valerio. The brand launched DTC with one product and a mission to help people “know more, fear less, and choose better.” Today, the brand consists of 15 SKUs across two primary ranges. The Advanced Clinical Line and The Essential Line are priced from €13 to €41.Label Capital focuses on investments in consumer healthcare, beauty & personal care, food & beverage, and entertainment & lifestyle sectors. The firm's first investment was last November in the French aesthetic clinic Innerskin. Investments in Paris Dental Studios and niche fragrance brand Ex Nihilo and allergy care brand Curex followed.WHY: This strategic investment will fuel expansion beyond the Spanish market.DETAILS:The €5 million minority investment will help the company expand geographically.IVB has 20,000 clients online and over 700 points of sale in Spain.The brand has 23 employees and achieved double-digit growth month on month, with sales projections of more than €10 million for 2024.Dr. Viña Bas has a large following, with 309,000 followers on Instagram and a popular podcast on Spotify that’s broadly listened to in South America.Andersen has advised Label Capital on its investment in IVB Wellness Lab.